Susquehanna International Group, LLP Mirati Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$41.99 - $62.38 $5.77 Million - $8.58 Million	-137,501 Reduced 48.52%	145,890 $8.57 Million
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $1.62 Million - $2.64 Million	58,290 Added 25.9%	283,391 $12.3 Million
Q2 2023 Aug 11, 2023	SELL	$36.13 - $49.49 $4.97 Million - $6.81 Million	-137,511 Reduced 37.92%	225,101 $8.13 Million
Q1 2023 May 16, 2023	BUY	$36.54 - $54.26 $10.8 Million - $16 Million	294,921 Added 435.69%	362,612 $13.5 Million
Q4 2022 Feb 14, 2023	SELL	$41.27 - $98.62 $498,871 - $1.19 Million	-12,088 Reduced 15.15%	67,691 $3.07 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $4.57 Million - $6.66 Million	76,799 Added 2577.15%	79,779 $5.57 Million
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $1.5 Million - $3.4 Million	-38,316 Reduced 92.78%	2,980 $200,000
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $279,624 - $556,777	3,688 Added 9.81%	41,296 $3.4 Million
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $6.73 Million - $9.7 Million	-50,976 Reduced 57.55%	37,608 $5.52 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $3.41 Million - $4.57 Million	25,775 Added 41.04%	88,584 $15.7 Million
Q2 2021 Aug 11, 2021	BUY	$144.0 - $179.73 $1.38 Million - $1.73 Million	9,605 Added 18.05%	62,809 $10.1 Million
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $6.51 Million - $9.08 Million	40,961 Added 334.57%	53,204 $9.11 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $263,169 - $390,198	1,624 Added 15.29%	12,243 $2.69 Million
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $312,257 - $461,163	2,757 Added 35.07%	10,619 $1.76 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $868,440 - $1.45 Million	-12,060 Reduced 60.54%	7,862 $898,000
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $2.16 Million - $3.6 Million	-30,948 Reduced 60.84%	19,922 $1.53 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $1.93 Million - $3.52 Million	27,278 Added 115.62%	50,870 $6.56 Million
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $6.31 Million - $8.88 Million	-81,053 Reduced 77.46%	23,592 $1.84 Million
Q2 2019 Aug 16, 2019	BUY	$59.49 - $104.71 $325,886 - $573,601	5,478 Added 5.52%	104,645 $10.8 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $3.24 Million - $5.7 Million	54,391 Added 121.47%	99,167 $10.2 Million
Q1 2019 May 15, 2019	SELL	$43.65 - $78.95 $105,327 - $190,506	-2,413 Reduced 5.11%	44,776 $3.28 Million
Q1 2018 May 15, 2018	BUY	$17.2 - $34.95 $5,486 - $11,149	319 Added 0.68%	47,189 $1.45 Million
Q3 2017 Nov 14, 2017	BUY	$4.7 - $11.7 $220,289 - $548,379	46,870	46,870 $548,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account